Freyr assisted a Dutch-based pharmaceutical company in submitting its IR to the United States Food and Drug Administration (US FDA) for its specialized product.
The company lacked experience in drafting a proper response in such an endeavor. With adequate support from the Publishing Team, the DMF was properly reviewed, shared with the client for review, and submitted to the Health Authority on time.
Download the proven case to learn how Freyr’s RA team assisted this Dutch-based biopharmaceutical client.
Fill the form below to download the Case Study
